← All organizations

Tercica

For profitContributed to NME

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

First NDA

Last known activity

Oct 1, 2008

Acquired by Ipsen on Oct 17, 2008

Timeline

2000s

Jan 1, 2002
Tercica— Founded
Aug 30, 2005
mecasermin— NDA Organization
Oct 17, 2008
Ipsen— Acquired By

Drugs by trial phase (2 distinct, 3 trials)

Phase 3 (1 own, 0 via acquisition)

mecasermin

Other trials (1 own, 0 via acquisition)

somatropin

Indications

Studied for

Marketed drugs (1)

mecasermin

Recent trials (3)

NCT00764699CollaboratorPhase 2/Phase 3Oct 1, 2008
NCT00684957CollaboratorN/AJan 1, 2008
NCT00516386CollaboratorPhase 1/Phase 2Mar 1, 2007

Details

Founded: Brisbane, CA, US Jan 1, 2002
First NDA: Aug 30, 2005
Last known activity: Oct 1, 2008

Designations held

Orphan drug

Notes

Acquired by Ipsen